<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-31T07:34:57+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药物警戒制度上升到战略层面 | DRR专题· 新理念</title>
    <updated>2020-12-30T18:21:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/bCKLxueB_XUR5JTx6YqEFA</id>
    <link href="https://mp.weixin.qq.com/s/bCKLxueB_XUR5JTx6YqEFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优先审评审批和特别审批：聚焦临床价值 | DRR·注册程序</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/F2ptxxA6oS8otlxF3mnaow</id>
    <link href="https://mp.weixin.qq.com/s/F2ptxxA6oS8otlxF3mnaow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201230 本周职位精选：谷孚招聘科技项目主管 | 招聘</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/-AUxdNYBeFCVa5OlEuDVnQ</id>
    <link href="https://mp.weixin.qq.com/s/-AUxdNYBeFCVa5OlEuDVnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究阶段两大加速通道 | DRR·注册程序</title>
    <updated>2020-12-28T23:19:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/mVPMO6BKqt-A9Tzu5mNcFA</id>
    <link href="https://mp.weixin.qq.com/s/mVPMO6BKqt-A9Tzu5mNcFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物战略升级 | 江湖</title>
    <updated>2020-12-27T23:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/xDijcpqggA3gURBmC41EPA</id>
    <link href="https://mp.weixin.qq.com/s/xDijcpqggA3gURBmC41EPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>来凯医药一类新药LAE002/Afuresertib和LAE005临床试验获批 | 新闻稿</title>
    <updated>2020-12-27T23:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/tCFlqfzTGrnCcOJZlmKsrQ</id>
    <link href="https://mp.weixin.qq.com/s/tCFlqfzTGrnCcOJZlmKsrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光药理解的“创新”内涵 | DRR专题·转型</title>
    <updated>2020-12-26T22:39:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/_R7-X8TUUMAicFSKtG651Q</id>
    <link href="https://mp.weixin.qq.com/s/_R7-X8TUUMAicFSKtG651Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研发客独家资本市场调研报告+药品注册法规蓝皮书，这里有机会免费拿！</title>
    <updated>2020-12-25T22:51:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/yjW-cSpZmOyLPM0Owa-iAA</id>
    <link href="https://mp.weixin.qq.com/s/yjW-cSpZmOyLPM0Owa-iAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>用糖工程毕赤酵母敲开低成本抗体开发之门｜江湖</title>
    <updated>2020-12-24T22:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/vCN9PPA7v9js5yaEqdZW7g</id>
    <link href="https://mp.weixin.qq.com/s/vCN9PPA7v9js5yaEqdZW7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>极目生物获得国内首个治疗UME临床试验批件! 脉络膜上腔给药注射给患者带来更多福音|新闻稿</title>
    <updated>2020-12-24T22:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/9h6tDffl4F6N7lFWO9zQpQ</id>
    <link href="https://mp.weixin.qq.com/s/9h6tDffl4F6N7lFWO9zQpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>快来填写研发客资本市场调研问卷</title>
    <updated>2020-12-24T22:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/n67Kf7I40HaOmULCxXAJpw</id>
    <link href="https://mp.weixin.qq.com/s/n67Kf7I40HaOmULCxXAJpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科伦药业从仿到创的战略变化 | DRR专题 · 转型</title>
    <updated>2020-12-24T02:46:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/gCLT1jSkuXWIrLCOg4OflA</id>
    <link href="https://mp.weixin.qq.com/s/gCLT1jSkuXWIrLCOg4OflA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020即将翻篇，您对明年有信心吗？快来填写研发客调研问卷</title>
    <updated>2020-12-24T02:46:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/DHkjfxr6znt-abdAA4XyMg</id>
    <link href="https://mp.weixin.qq.com/s/DHkjfxr6znt-abdAA4XyMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新法能否真正保护创新药？| 法规观察</title>
    <updated>2020-12-23T00:39:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/3d5-5-yJSlFNFxBqParQ4A</id>
    <link href="https://mp.weixin.qq.com/s/3d5-5-yJSlFNFxBqParQ4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创业老兵娄实的新起点 | 遇见</title>
    <updated>2020-12-20T21:31:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/hAAiXfDr0_yDovKyDvCpVw</id>
    <link href="https://mp.weixin.qq.com/s/hAAiXfDr0_yDovKyDvCpVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Bionnova生物医药创新者论坛：速度与安全研讨会回顾 | 新闻稿</title>
    <updated>2020-12-20T21:31:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/5qEjvs2u56lZYzbe3a8cwg</id>
    <link href="https://mp.weixin.qq.com/s/5qEjvs2u56lZYzbe3a8cwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准XPOVIO®用于治疗接受过至少一线治疗的多发性骨髓瘤患者 | 新闻稿</title>
    <updated>2020-12-20T21:31:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/uxihwzJirAxUYDTAVWmfCA</id>
    <link href="https://mp.weixin.qq.com/s/uxihwzJirAxUYDTAVWmfCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>